As of 2025-09-19, the Relative Valuation of VistaGen Therapeutics Inc (VTGN) is (19.97) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.04 USD, the upside of VistaGen Therapeutics Inc based on Relative Valuation is -757.0%.
The range of the Relative Valuation is (16.03) - (22.36) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.4x - 15.8x | 14.2x |
| Forward P/E multiples | 11.3x - 17.3x | 14.1x |
| Fair Price | (16.03) - (22.36) | (19.97) |
| Upside | -627.4% - -835.4% | -757.0% |
| Date | P/E |
| 2025-09-08 | -2.47 |
| 2025-09-05 | -2.52 |
| 2025-09-04 | -2.56 |
| 2025-09-03 | -2.61 |
| 2025-09-02 | -2.49 |
| 2025-08-29 | -2.37 |
| 2025-08-28 | -2.29 |
| 2025-08-27 | -2.25 |
| 2025-08-26 | -2.20 |
| 2025-08-25 | -2.15 |
| 2025-08-22 | -2.25 |
| 2025-08-21 | -2.17 |
| 2025-08-20 | -2.20 |
| 2025-08-19 | -2.25 |
| 2025-08-18 | -2.41 |
| 2025-08-15 | -2.35 |
| 2025-08-14 | -2.09 |
| 2025-08-13 | -2.08 |
| 2025-08-12 | -2.03 |
| 2025-08-11 | -2.01 |
| 2025-08-08 | -2.10 |
| 2025-08-07 | -1.93 |
| 2025-08-06 | -2.10 |
| 2025-08-05 | -2.07 |
| 2025-08-04 | -2.06 |
| 2025-08-01 | -2.07 |
| 2025-07-31 | -2.03 |
| 2025-07-30 | -2.09 |
| 2025-07-29 | -2.17 |
| 2025-07-28 | -2.26 |
| 2025-07-25 | -2.18 |
| 2025-07-24 | -1.92 |
| 2025-07-23 | -1.93 |
| 2025-07-22 | -1.80 |
| 2025-07-21 | -1.81 |
| 2025-07-18 | -1.81 |
| 2025-07-17 | -1.80 |
| 2025-07-16 | -1.75 |
| 2025-07-15 | -1.59 |
| 2025-07-14 | -1.69 |
| 2025-07-11 | -1.69 |
| 2025-07-10 | -1.72 |
| 2025-07-09 | -1.76 |
| 2025-07-08 | -1.74 |
| 2025-07-07 | -1.57 |
| 2025-07-03 | -1.42 |
| 2025-07-02 | -1.45 |
| 2025-07-01 | -1.42 |
| 2025-06-30 | -1.42 |
| 2025-06-27 | -1.40 |